Yahoo
Canadian Sec - Free Realtime Quote CAD

Rocket Doctor AI Inc. (AIDR.CN)

0.5800 -0.0100 (-1.69%)
As of 11:32:19 AM EDT. Market Open.
Chart Range Bar
Loading chart for AIDR.CN
  • Previous Close 0.5900
  • Open 0.6000
  • Bid 0.5700 x --
  • Ask 0.5800 x --
  • Day's Range 0.5700 - 0.6000
  • 52 Week Range 0.5200 - 0.9800
  • Volume 74,773
  • Avg. Volume 115,202
  • Market Cap (intraday) 56.199M
  • Beta (5Y Monthly) -0.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2300
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.55

Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and changed its name to Rocket Doctor AI Inc. in August 2025. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

www.treatment.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

AIDR.CN
17.14%
S&P/TSX Composite index (^GSPTSE)
12.77%

1-Year Return

AIDR.CN
12.12%
S&P/TSX Composite index (^GSPTSE)
25.80%

3-Year Return

AIDR.CN
176.19%
S&P/TSX Composite index (^GSPTSE)
74.90%

5-Year Return

AIDR.CN
96.96%
S&P/TSX Composite index (^GSPTSE)
73.68%

Analyst Insights

View More

Analyst Price Targets

1.55
1.55 Average
0.5800 Current
1.55 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    59.11M

  • Enterprise Value

    56.14M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.94

  • Price/Book (mrq)

    9.52

  • Enterprise Value/Revenue

    22.67

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -221.31%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    38.14k

  • Net Income Avi to Common (ttm)

    -2.01M

  • Diluted EPS (ttm)

    -0.2300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.3M

  • Total Debt/Equity (mrq)

    46.41%

  • Levered Free Cash Flow (ttm)

    -1.01M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: